- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05520606
Laparoscopic Pancreatoduodenectomy Versus Open Pancreatoduodenectomy
August 29, 2022 updated by: Renyi Qin, Tongji Hospital
Minimally Invasive Versus Open for Pancreatoduodenectomy:an Retrospective, Observational, Multicenter Real-world Study
This is a single, retrospective, real-world study to investigate the surgical outcomes of minimally invasive pancreatoduodenectomy and open pancreatoduodenectomy, with the perioperative characteristics and long-term overall survival being compared.
The investigators aimed to find out whether the minimally invasive surgery is safe and feasible for resectable lesions located in the pancreatic head and periampullary region.
And the investigators also want to find out patients with what kind of characteristic can be benefit from the minimally invasive surgery compared with the open approach.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Pancreatoduodenectomy (Whipple surgery) is a complex surgical procedure and has been accepted as the gold standard treatment for resectable lesions of the pancreatic head and periampullary region.To date, how surgeons can safely pass the learning curve of laparoscopic pancreatoduodenectomy (LPD) without potentially harming patients remains a question.
Around this topic, the investigators designed real-world study in a single center to retrospectively collect the PD surgeries since July 2014.
The investigators aimed to find out whether the minimally invasive surgery is safe and feasible for resectable lesions located in the pancreatic head and periampullary region.
And the investigators also want to find out patients with what kind of characteristic can be benefit from the minimally invasive surgery compared with the open approach.
Besides, the investigators also want to investigate the clinical characteristics of patients and perioperative outcomes of LPD procedures and aimed to develop and validate a difficulty scoring system for patient selection which could help facilitate a comprehensive and security understanding of LPD for surgeon during different stage of the learning curve.
Study Type
Observational
Enrollment (Actual)
800
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients who underwent PD surgeries in Tongji Hospital since January 2014 .
Description
Inclusion Criteria:
- Aged 18 to 80 years.
- Patients underwent PD surgeries.
Exclusion Criteria:
- Peritoneal seeding or metastasis to distant sites;
- Incomplete clinical data.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
minimally invasive surgery
laparoscopic pancreatoduodenectomy.
|
Pancreatoduodenectomy (Whipple surgery) is a complex surgical procedure and has been accepted as the gold standard treatment for resectable lesions of the pancreatic head and periampullary region
|
open surgery
open pancreatoduodenectomy
|
Pancreatoduodenectomy (Whipple surgery) is a complex surgical procedure and has been accepted as the gold standard treatment for resectable lesions of the pancreatic head and periampullary region
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Postoperative length of stay
Time Frame: up to 90 days
|
defined as the time from being admitted to hospital to discharge
|
up to 90 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Overall survival
Time Frame: through study completion, an average of 5 year
|
defined as the duration from the first day after surgery to either the date of death or the last follow-up
|
through study completion, an average of 5 year
|
Operation time
Time Frame: intraoperative
|
defined as the time from skin incision or trocar placement to complete skin closure
|
intraoperative
|
postoperative complications
Time Frame: up to 90 days
|
Postoperative complications were reviewed within 90 days after surgery and graded according to Clavien-Dindo (CD) classification system.
Postoperative biliary leakage, hemorrhage, and liver failure.
Wound infection was defined as purulent drainage from the incision or/and positive findings of culture of the fluid or tissue aseptically obtained from the incision.
|
up to 90 days
|
Reoperation within 90 days
Time Frame: up to 90 days
|
defined as any reoperation within 90 days
|
up to 90 days
|
Mortality
Time Frame: up to 90 days
|
defined as any death within 30 days and 90 days, respectively
|
up to 90 days
|
Readmission within 90 days
Time Frame: up to 90 days
|
defined as any readmission within 90 days
|
up to 90 days
|
R0 resection
Time Frame: intraoperative
|
defined as tumor-free margins in all the reported surgical margins (biliary and circumferential margins
|
intraoperative
|
Intraoperative blood loss
Time Frame: intraoperative
|
recorded by the anesthetist using a vacuum system
|
intraoperative
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2014
Primary Completion (Actual)
December 30, 2019
Study Completion (Actual)
December 30, 2021
Study Registration Dates
First Submitted
August 19, 2022
First Submitted That Met QC Criteria
August 29, 2022
First Posted (Actual)
August 30, 2022
Study Record Updates
Last Update Posted (Actual)
August 30, 2022
Last Update Submitted That Met QC Criteria
August 29, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- TJDBPS11
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Resectable Lesions Located in the Pancreatic Head or Periampullary Region
-
Wakayama Medical UniversityUnknownDisease of Pancreatic Head or Periampullary Lesions to Require PancreaticoduodenectomyTaiwan
-
Texas Tech University Health Sciences Center, El...CompletedPancreatic or Peripancreatic Lesions | Lesions in the Esophagus, Stomach, Duodenum or Rectum | Mediastinal ( Chest) Masses | Enlarged Lymph NodesUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingPancreatic Adenocarcinoma | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Malignant Neoplasm | Recurrent Colorectal Carcinoma | Pancreatic Neuroendocrine Carcinoma | Malignant Head and Neck Neoplasm | Stage III Nasopharyngeal Carcinoma... and other conditionsUnited States
Clinical Trials on pancreatoduodenectomy
-
Fudan UniversityWest China Hospital; Tongji Hospital; Qilu Hospital of Shandong University; Zhejiang... and other collaboratorsRecruitingBorderline Resectable Pancreatic CancerChina
-
Seoul National University HospitalCompleted
-
Southwest Hospital, ChinaUnknownPancreatic Cancer | Periampullary CarcinomaChina
-
University of PecsNot yet recruitingPancreatic Cancer
-
Hospital Universitari de BellvitgeCompleted
-
Peking Union Medical College HospitalUnknown
-
GEM Hospital & Research CenterCompletedCholangio Carcinoma | Adenocarcinoma of Head of Pancreas | Duodenal Adenocarcinoma | Carcinoma of Ampulla of VaterIndia
-
General Hospital GroeningeCompletedPancreatic NeoplasmsBelgium
-
University Hospital, MontpellierUniversité MontpellierCompletedPancreatoduodenectomy
-
Institut Paoli-CalmettesCompletedPancreas Neoplasm